Elucidating hepatocellular carcinoma progression: a novel prognostic miRNA-mRNA network and signature analysis

被引:4
作者
Wang, Fei [1 ]
Kang, Xichun [1 ]
Li, Yaoqi [1 ]
Lu, Jianhua [1 ]
Liu, Xiling [1 ]
Yan, Huimin [1 ]
机构
[1] Shijiazhuang Fifth Hosp, Clin Res Ctr, Shijiazhuang, Hebei, Peoples R China
关键词
Hepatocellular carcinoma; miRNA; Prognosis; miRNA-mRNA network; COLORECTAL-CANCER; GENES; COEXPRESSION; PREDICTION; BIOMARKERS; RECURRENCE; MIR-139-5P; MICRORNAS; HCC;
D O I
10.1038/s41598-024-55806-y
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
There is increasing evidence that miRNAs play an important role in the prognosis of HCC. There is currently a lack of acknowledged models that accurately predict patient prognosis. The aim of this study is to create a miRNA-based model to precisely forecast a patient's prognosis and a miRNA-mRNA network to investigate the function of a targeted mRNA. TCGA miRNA dataset and survival data of HCC patients were downloaded for differential analysis. The outcomes of variance analysis were subjected to univariate and multivariate Cox regression analyses and LASSO analysis. We constructed and visualized prognosis-related models and subsequently used violin plots to probe the function of miRNAs in tumor cells. We predicted the target mRNAs added those to the String database, built PPI protein interaction networks, and screened those mRNA using Cytoscape. The hub mRNA was subjected to GO and KEGG analysis to determine its biological role. Six of them were associated with prognosis: hsa-miR-139-3p, hsa-miR-139-5p, hsa-miR-101-3p, hsa-miR-30d-5p, hsa-miR-5003-3p, and hsa-miR-6844. The prognostic model was highly predictive and consistently performs, with the C index exceeding 0.7 after 1, 3, and 5 years. The model estimated significant differences in the Kaplan-Meier plotter and the model could predict patient prognosis independently of clinical indicators. A relatively stable miRNA prognostic model for HCC patients was constructed, and the model was highly accurate in predicting patients with good stability over 5 years. The miRNA-mRNA network was constructed to explore the function of mRNA.
引用
收藏
页数:16
相关论文
共 55 条
[1]   hsa_circ_0003410 promotes hepatocellular carcinoma progression by increasing the ratio of M2/M1 macrophages through the miR-139-3p/CCL5 axis [J].
Cao, Pei ;
Ma, Bo ;
Sun, Ding ;
Zhang, Weigang ;
Qiu, Junyi ;
Qin, Lei ;
Xue, Xiaofeng .
CANCER SCIENCE, 2022, 113 (02) :634-647
[2]   Utility of Liquid Biopsy Analysis in Detection of Hepatocellular Carcinoma, Determination of Prognosis, and Disease Monitoring: A Systematic Review [J].
Chen, Vincent L. ;
Xu, Dabo ;
Wicha, Max S. ;
Lok, Anna S. ;
Parikh, Neehar D. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (13) :2879-+
[3]   An Integrated Approach Identifies Mediators of Local Recurrence in Head and Neck Squamous Carcinoma [J].
Citron, Francesca ;
Armenia, Joshua ;
Franchin, Giovanni ;
Polesel, Jerry ;
Talamini, Renato ;
D'Andrea, Sara ;
Sulfaro, Sandro ;
Croce, Carlo M. ;
Klement, William ;
Otasek, David ;
Pastrello, Chiara ;
Tokar, Tomas ;
Jurisica, Igor ;
French, Deborah ;
Bomben, Riccardo ;
Vaccher, Emanuela ;
Serraino, Diego ;
Belletti, Barbara ;
Vecchione, Andrea ;
Barzan, Luigi ;
Baldassarre, Gustavo .
CLINICAL CANCER RESEARCH, 2017, 23 (14) :3769-3780
[4]  
Dang XW, 2021, AGING-US, V13, P20094, DOI 10.18632/aging.203016
[5]   KRAS Mutation -Responsive miR-139-5p inhibits Colorectal Cancer Progression and is repressed by Wnt Signaling [J].
Du, Feng ;
Cao, Tianyu ;
Xie, Huahong ;
Li, Ting ;
Sun, Lina ;
Liu, Hao ;
Guo, Hao ;
Wang, Xin ;
Liu, Qi ;
Kim, Taewan ;
Franklin, Jeffrey L. ;
Graves-Deal, Ramona ;
Han, Weili ;
Tian, Zuhong ;
Ge, Minghui ;
Nie, Yongzhan ;
Fan, Daiming ;
Coffey, Robert J. ;
Lu, Yuanyuan ;
Zhao, Xiaodi .
THERANOSTICS, 2020, 10 (16) :7335-7350
[6]  
Eini Maryam, 2022, Avicenna Journal of Medical Biotechnology, V14, P154, DOI [10.18502/ajmb.v14i2.8882, 10.18502/ajmb.v14i2.8882]
[7]   Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma [J].
Feng, Jiao ;
Li, Jingjing ;
Wu, Liwei ;
Yu, Qiang ;
Ji, Jie ;
Wu, Jianye ;
Dai, Weiqi ;
Guo, Chuanyong .
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2020, 39 (01)
[8]   NAFLD-driven HCC: Safety and efficacy of current and emerging treatment options [J].
Foerster, Friedrich ;
Gairing, Simon Johannes ;
Mueller, Lukas ;
Galle, Peter Robert .
JOURNAL OF HEPATOLOGY, 2022, 76 (02) :446-457
[9]   Targeting Immune Cells in the Tumor Microenvironment of HCC: New Opportunities and Challenges [J].
Hao, Xiaopei ;
Sun, Guangshun ;
Zhang, Yao ;
Kong, Xiangyi ;
Rong, Dawei ;
Song, Jinhua ;
Tang, Weiwei ;
Wang, Xuehao .
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
[10]   miRNA-based biomarkers, therapies, and resistance in Cancer [J].
He, Boxue ;
Zhao, Zhenyu ;
Cai, Qidong ;
Zhang, Yuqian ;
Zhang, Pengfei ;
Shi, Shuai ;
Xie, Hui ;
Peng, Xiong ;
Yin, Wei ;
Tao, Yongguang ;
Wang, Xiang .
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2020, 16 (14) :2628-2647